Pharmaceutical Filtration Consumables Market

The pharmaceutical filtration consumables market is projected to reach USD 18.03 billion by 2030 from USD 11.96 billion in 2025, registering a CAGR of 8.5% between 2025 and 2030. The growth of the pharmaceutical filtration consumables market is driven by key factors, including technological innovations, advanced membrane and filter designs, as well as a shift towards single-use technologies (SUTs) and disposable products.

To know about the assumptions considered for the study download the pdf brochure

Key players in the pharmaceutical filtration consumables industry with a strong footprint include Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Parker-Hannifin Corporation (US), Eaton Corporation Plc (Ireland), Thermo Fisher Scientific, Inc. (US), Solventum (US), Donaldson Company, Inc. (US), Porvair Plc (UK), and Alfa Laval Corporate AB (Sweden), among others. Companies in this space are adopting differentiated expansion strategies to strengthen their footprint and elevate their technology portfolios. For example, Parker-Hannifin, Solventum, and Donaldson are advancing their positions by scaling single-use filtration lines, upgrading sterilizing-grade membrane offerings, and investing in higher-capacity particulate control solutions tailored for biologics and vaccine manufacturing. Meanwhile, Thermo Fisher Scientific and Danaher are enhancing their consumables portfolios through integrated bioprocess workflows that combine pre-filters, depth filters, virus-reduction membranes, and in-line quality monitoring tools to support seamless upstream and downstream operations.

In 2025, Sartorius also introduced a new high-throughput PFAS-free Sartopore Evo membrane filter for fill-finish and other sterile filtration steps, designed to increase filtration capacity and reduce material waste, reinforcing its sustainability positioning in single-use filtration consumables

In September 2025, Thermo Fisher Scientific acquired Solventum’s Purification and Filtration Business.

Merck KGaA (Germany)

Merck’s Life Science business, under the MilliporeSigma brand, supplies a broad range of sterilizing-grade filters, tangential-flow filtration cassettes, and virus filters that support aseptic processing, vaccine manufacturing, and advanced biologics such as monoclonal antibodies and cell & gene therapies. The company is strengthening this position with a new climate-neutral USD 150 million filtration manufacturing facility in Blarney, Ireland, scheduled to start production in late 2025. The facility will focus on devices for aseptic processing, tangential flow filtration, and virus filtration, thereby enhancing the security of supply for high-value filter consumables.

Danaher Corporation (US)

Danaher has established itself as a major player in the pharmaceutical filtration consumables market. Through its bioprocessing brands, including Cytiva and Pall, the company offers advanced filtration membranes, depth filters, and fully integrated single-use systems designed to support the production of biologics, vaccines, and cell therapies. Danaher prioritizes process reliability, contamination control, and scalability, which enables manufacturing companies to consistently produce high-quality outputs. Current investments in manufacturing capacity include the expansion of Cytiva's filtration facilities to meet the growing demand for high-throughput, end-to-end filtration solutions in next-generation biomanufacturing.

Sartorius (Germany)

Sartorius focuses on integrated single-use filtration solutions, offering sterile filters, Sartopore membrane cartridges, and pre-configured single-use filter transfer assemblies that are qualified, sterile, and designed to meet EU GMP Annex 1 PUPSIT requirements for final filling, helping customers standardize operations and reduce operator error. Its membrane portfolio spans PES and other polymeric filter types optimized for high flow, low protein binding, and robust microbial retention, supporting critical steps from buffer and media preparation to sterile filtration of biologics and vaccines.

Market Ranking

The pharmaceutical filtration consumables market is characterized by significant consolidation. The major companies in the market reinforce their positions through strategic acquisitions, advanced manufacturing capabilities, and extensive distribution networks.

Merck KGaA (Germany) offers a broad, Emprove-qualified filter portfolio, including sterilizing-grade cartridges, virus filters, and single-use components that help drug manufacturers meet stringent regulatory and quality requirements. Danaher (US), through its Cytiva and Pall brands, delivers integrated depth filtration, sterilizing-grade membranes, and single-use platforms that enable scalable, contamination-free bioprocessing. Solventum (US) strengthens filtration operations with novel depth media, bacterial retention filters, and contamination-control technologies for sterile drug production. Parker-Hannifin (US) expands its presence through high-purity filtration, gas-liquid separation systems, and process protection filters designed for reliable upstream and downstream pharmaceutical workflows. Thermo Fisher Scientific (US) is a major player in the market, delivering integrated single-use bioprocessing solutions, depth, and sterilizing-grade filtration that support scalable, contamination-controlled manufacturing of vaccines, monoclonal antibodies, and cell & gene therapies.

The rapid development of pharmaceutical consumables is driven by advances in high-performance filter membranes, single-use capsules and cartridges, and pre-assembled sterile flow paths that streamline bioprocessing. This demand is fueled by the growth of biologics, vaccines, and cell and gene therapies, as well as increasing regulatory expectations for sterility assurance and contamination control in aseptic operations.

Industry leaders consist of a diverse group of regional suppliers and specialized innovators. They are scaling up by focusing on proprietary consumables, custom assemblies, and providing local technical support for small and mid-scale manufacturers. These companies are increasingly differentiating themselves through application-specific filter designs, rapid assembly of single-use sets, and partnerships with CDMOs and emerging therapy developers that require flexible, customized filtration capabilities.

Related Reports:

Pharmaceutical Filtration Consumables Market by Type (Membrane Filter, Depth Filter, Virus Filter, Air Filter, Assemblies), Technique (Ultrafiltration), Sterility Type (Sterile), Application (API, Protein), Scale, End User - Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com